Table 2.
Overall survival and cancer-specific survival analysis in patients with primary Gastrointestinal DLBCL.
| Survival (%) | 95%CI lower | 95%CI upper | |
|---|---|---|---|
| Overall survival | |||
| Primary gastrointestinal DLBCL (all) | |||
| 1-year | 65.6 | 64.7 | 66.5 |
| 3-year | 57.1 | 56.2 | 58.1 |
| 5-year | 51.3 | 50.4 | 52.3 |
| 10-year | 39.2 | 38.2 | 40.2 |
| Primary gastrointestinal DLBCL located in stomach | |||
| 1-year | 62.4 | 61.2 | 63.7 |
| 3-year | 54.5 | 53.2 | 55.8 |
| 5-year | 48.8 | 47.4 | 50.1 |
| 10-year | 36.8 | 35.4 | 38.2 |
| Primary gastrointestinal DLBCL located in small intestine | |||
| 1-year | 70.1 | 68.5 | 71.9 |
| 3-year | 60.7 | 58.9 | 62.6 |
| 5-year | 55.4 | 53.5 | 57.3 |
| 10-year | 42.9 | 40.9 | 45.1 |
| Primary gastrointestinal DLBCL located in colorectum | |||
| 1-year | 67.9 | 66.0 | 69.9 |
| 3-year | 59.4 | 57.3 | 61.5 |
| 5-year | 52.8 | 50.6 | 55.0 |
| 10-year | 40.8 | 38.5 | 43.2 |
| Cancer-specific survival | |||
| Primary gastrointestinal DLBCL (all) | |||
| 1-year | 71.8 | 70.9 | 72.7 |
| 3-year | 66.0 | 65.0 | 66.9 |
| 5-year | 63.5 | 62.5 | 64.5 |
| 10-year | 59.0 | 57.9 | 60.1 |
| Primary gastrointestinal DLBCL located in stomach | |||
| 1-year | 68.9 | 67.6 | 70.1 |
| 3-year | 63.4 | 62.1 | 64.7 |
| 5-year | 61.5 | 60.1 | 62.8 |
| 10-year | 57.1 | 55.7 | 58.6 |
| Primary gastrointestinal DLBCL located in small intestine | |||
| 1-year | 75.5 | 73.9 | 77.1 |
| 3-year | 68.7 | 67.0 | 70.5 |
| 5-year | 65.6 | 63.8 | 67.5 |
| 10-year | 61.0 | 59.0 | 63.1 |
| Primary gastrointestinal DLBCL located in colorectum | |||
| 1-year | 74.7 | 72.8 | 76.6 |
| 3-year | 69.2 | 67.2 | 71.2 |
| 5-year | 66.0 | 63.9 | 68.2 |
| 10-year | 61.3 | 59.0 | 63.7 |
DLBCL: diffuse large B-cell lymphoma; CI: confidence interval.